Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS): study protocol for a prospective, randomized, double-blind, non-inferiority trial

BACKGROUND: Tranexamic acid (TXA) has been routinely delivered in multisegmental spinal decompression and bone graft fusion surgeries with satisfactory outcomes in minimizing gross blood loss and transfusion demands. However, concerns remain that intravenously delivered TXA (ivTXA) may increase risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Shangyi, Tao, Liyuan, Mahmood, Feroze, Xu, Derong, Ren, Zhinan, Chen, Xin, Sheng, Lin, Zhuang, Qianyu, Li, Shugang, Huang, Yuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373130/
https://www.ncbi.nlm.nih.gov/pubmed/30755256
http://dx.doi.org/10.1186/s13063-019-3231-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373130/
https://www.ncbi.nlm.nih.gov/pubmed/30755256
http://dx.doi.org/10.1186/s13063-019-3231-9

Ejemplares similares